The British Standards Institute (BSI) has granted the OncoSil System the prestigious European CE marking. This certification validates the OncoSil device and its clinical performance in treating locally advanced pancreatic cancer. Additionally, OncoSil has been designated as a breakthrough therapy, acknowledging its potential to address unmet medical needs.